Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Total Current Liabilities (2024 - 2025)

Historic Total Current Liabilities for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $676000.0.

  • Kairos Pharma's Total Current Liabilities changed N/A to $676000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $676000.0, marking a year-over-year change of. This contributed to the annual value of $992000.0 for FY2024, which is N/A changed from last year.
  • Per Kairos Pharma's latest filing, its Total Current Liabilities stood at $676000.0 for Q2 2025.
  • Kairos Pharma's Total Current Liabilities' 5-year high stood at $1.7 million during Q3 2024, with a 5-year trough of $676000.0 in Q2 2025.